Clinical Trial

Cancer Literacy Education and Awareness Resources for Prostate Care

Study acronym: CLEAR-PC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The CLEAR-PC project addresses the critical issue of low health literacy in prostate cancer prevention and care, recognising that inadequate health literacy leads to difficulties in understanding complex medical information, limits shared decision making, and increases health inequalities. Given the high prevalence and complexity of prostate cancer, the project aims to design and development of a comprehensive strategy to improve health literacy in the Prostate cancer prevention and care, considering individual capacities, the role of healthcare professionals and organisations, and the influence of social and cultural contexts. In the design and development of this new strategy, the investigators apply both action research and cocreation methodologies because by involving all stakeholders (general population, vulnerable population patients, health professionals, policy makers and other target groups), we ensure that the resulting strategy is user-centred, implementable and responsive to their needs. The design and development of the new strategy will follow a systematic cycle: (a) problem diagnosis by assessing individual contexts, healthcare professionals, organisational aspects and the social framework; (b) adaptation of existing health literacy tools to the specific context of prostate cancer prevention and care, integrating them into a new strategy, followed by evaluation of their usability and acceptability; and (c) observation of results in practice and reflection. Co-creation will be a critical component throughout this process, ensuring that stakeholders are actively involved at every stage, from diagnosis of challenges to refinement and validation of solutions. The consortium, composed of institutions from Spain, Portugal, Croatia, Belgium, the Netherlands and Cyprus, leverages multidisciplinary expertise to create digital and non-innovative tools and educational resources to address public health disparities, reduce misinformation and support decision-making on prostate cancer prevention and care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-23.
Trial Details
NCT Number NCT07437482
Lead Sponsor Universidad Miguel Hernandez de Elche
Collaborators: Canary Islands Health Service, Ordem dos Psicólogos, Public Open University Čakovec, Thomas More University of Applied Sciences, Erasmus Medical Center, Center for Social Innovation, Instituto de Investigación Sanitaria y Biomédica de Alicante, Europa UOMO, Spanish Society of Family and Community Medicine, FISABIO (Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community), Universidad de Murcia, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, FEFOC fundation, Ministry of Health - Government of the Principality of Asturias, Asturias Public Health Service (SESPA), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia
Conditions Health Literacy, Prostate Cancer
Enrollment 3,100 participants
Start Date 2026-03
Primary Completion 2028-03 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-03